WHO GRADE 2 GLIOMA
Clinical trials for WHO GRADE 2 GLIOMA explained in plain language.
Never miss a new study
Get alerted when new WHO GRADE 2 GLIOMA trials appear
Sign up with your email to follow new studies for WHO GRADE 2 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with brain tumors: targeted drug may beat chemo
Disease control Recruiting nowThis study tests whether a targeted drug called selumetinib works as well as or better than standard chemotherapy (carboplatin and vincristine) for children and young adults (ages 2-21) with a slow-growing brain tumor called low-grade glioma that does not have certain genetic cha…
Matched conditions: WHO GRADE 2 GLIOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Engineered immune cells take on recurrent brain tumors in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called anti-GARP CAR T-cell therapy for people with recurrent high-grade glioma, a type of aggressive brain cancer. The therapy involves taking a patient's own immune cells, modifying them in a lab to recognize and attack cancer cells,…
Matched conditions: WHO GRADE 2 GLIOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC